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Adipose tissue fibrosis development blocks adipo-
cyte hypertrophy and favors ectopic lipid accumula-
tion. Here, we show that adipose tissue fibrosis is
associated with obesity and insulin resistance in hu-
mans and mice. Kinetic studies in C3H mice fed a
high-fat diet show activation of macrophages and
progression of fibrosis along with adipocyte meta-
bolic dysfunction and death. Adipose tissue fibrosis
is attenuated by macrophage depletion. Impairment
of Toll-like receptor 4 signaling protects mice from
obesity-induced fibrosis. The presence of a func-
tional Toll-like receptor 4 on adipose tissue hemato-
poietic cells is necessary for the initiation of adipose
tissue fibrosis. Continuous low-dose infusion of the
Toll-like receptor 4 ligand, lipopolysaccharide, pro-
motes adipose tissue fibrosis. Ex vivo, lipopolysac-
charide-mediated induction of fibrosis is prevented
by antibodies against the profibrotic factor TGFb1.
Together, these results indicate that obesity and en-
dotoxemia favor the development of adipose tissue
fibrosis, a condition associated with insulin resis-
tance, through immune cell Toll-like receptor 4.
INTRODUCTION
Adipose tissue (AT) serves as a long-term energy reserve that
can be mobilized during food deprivation. Under excess energy
conditions, AT expands through storage of fatty acids as triglyc-
erides. AT expansion protects other organs against chronic lipid1116 Cell Reports 7, 1116–1129, May 22, 2014 ª2014 The Authorsoverload, leading to metabolic disorders. Indeed, facilitated
AT expansion is associated in transgenic mouse models with a
better metabolic state (Kim et al., 2007; Kusminski et al., 2012;
Medina-Gomez et al., 2007; Virtue and Vidal-Puig, 2008). Lack
of AT, as seen in lipodystrophy, leads to severemetabolic abnor-
malities (Gandotra et al., 2011; Pajvani et al., 2005). During AT
expansion in mice fed a high-fat diet (HFD), there is a remodeling
of the tissue to accommodate adipocyte growth (Strissel et al.,
2007). In the obese state, AT remodeling is characterized by im-
mune cell infiltration, cytokine release, and production of extra-
cellular matrix (ECM) (Sun et al., 2013). Mice lacking collagen
VI, a type of collagen found in human and mouse AT, show
increased expansion of AT and improvements in whole-body
energy homeostasis (Divoux et al., 2010; Khan et al., 2009).
Therefore, excessive collagen accumulation and development
of fibrosis can limit AT expandability, resulting in ectopic lipid
accumulation and development of metabolic syndrome.
Obesity in humans and mice is characterized by systemic and
AT inflammation (Cancello et al., 2005; Klimcakova et al., 2011a;
Weisberg et al., 2003; Xu et al., 2003). This state of low-grade
inflammation results in increased production of cytokines and
chemokines, primarily by macrophages (Horng and Hotamisligil,
2011). In liver and kidney, there is a close link between inflamma-
tion, production of ECM and development of fibrosis. In these
organs, there is mounting evidence that the immune Toll-like re-
ceptor 4 (TLR4) acts as a key regulator in fibrogenesis (Aoyama
et al., 2010; Campbell et al., 2011; Seki et al., 2007). A role for
TLR4 in ATmacrophage response has been shown, but its direct
contribution to AT fibrosis remains elusive (Poggi et al., 2007;
Saberi et al., 2009; Shi et al., 2006).
Despite its importance in the dynamics of AT remodeling and
consequences on metabolic status, the mechanisms controlling
AT fibrosis remain poorly understood. One of the limitations has
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Figure 1. Fibrosis Appearance during
Obesity in Adipose Tissues
(A) Centroid analysis of 18 fibrosis pathway genes in
subcutaneous adipose tissue from lean (LE), obese
(OB), and obese with metabolic syndrome (OB/MS)
individuals (n = 8 per group).
(B) mRNA levels of fibrosis genes in adipose tissue
from LE and OB/MS individuals (n = 8 per group).
(C) Expression of fibrosis genes in progenitors, ad-
ipocytes, and macrophages from human adipose
tissue (n = 5 per group).
(D) Changes during human preadipocyte differenti-
ation of extracellular matrix gene expression (n = 9).
(E) Centroid analysis of nine fibrosis pathway genes
in mouse adipose tissue (n = 6 per group).
(F) mRNA levels of fibrosis genes in adipose tissue
of C3H/HeOuJ mice fed normal chow diet (NCD)
and high-fat diet (HFD) for 4 weeks (n = 6 per group).
(G) Hydroxyproline content of epididymal fat in ad-
ipose tissue of C3H/HeOuJ mice fed normal chow
diet (NCD) and HFD for 8 weeks (n = 6 per group).
(H) Expression of fibrosis genes in progenitors,
adipocytes, and macrophages from C3H/HeOuJ
mouse adipose tissue after 6 weeks of HFD (n = 6
per group).
Data are presented for human (A–D) and mouse
(E–H) adipose tissues. Values represent mean ±
SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
See also Figure S1.been the lack of suitable mouse models. Here, we character-
ized AT fibrosis in humans and mice to determine whether
they share similar features. Unlike the commonly used
C57BL/6 mice, mice with a C3H background develop
AT fibrosis when obesity is induced by high-fat feeding. This
prompted us to investigate the role of TLR4 in C3H/HeJ mice
(which carry a spontaneous loss of function mutation of TLR4)
and in control C3H/HeOuJ mice treated with an inhibitor of
TLR4 signaling (Li et al., 2006). To determine whether immune
cells expressing TLR4 are instrumental in promoting AT fibrosis,
bone marrow transplantation and clodronate-mediated macro-
phage depletion were performed. The role of the prototypical
TLR4 ligand, lipopolysaccharide (LPS), was investigated in vivo
using continuous low-dose infusion of the endotoxin and
ex vivo in AT explants.Cell Reports 7, 1116–11RESULTS
Identification of aMouseModel of AT
Fibrosis Mimicking Human Obesity
In human subcutaneous AT, expression
of genes involved in fibrosis showed a
progression from lean to obese individ-
uals to reach the highest levels in obese
patients with metabolic syndrome (Fig-
ure 1A; Table S1). A similar pattern was
observed in human visceral AT (Fig-
ure S1A). Genes encoding ECM proteins,
such as collagen type I alpha 1
(COL1A1), collagen type VI alpha 3
(COL6A3), lumican (LUM), and tenascinC (TNC), were upregulated in obese patients with metabolic
syndrome compared to lean and healthy individuals (Fig-
ure 1B). These genes showed high expression in the progeni-
tor cells of AT stromavascular fraction (SVF) (Figures 1C and
S1B). Accordingly, there was a downregulation of fibrosis-
related gene expression during human adipocyte differentia-
tion (Figure 1D).
In search for a mouse model of progressive AT fibrosis dur-
ing the development of obesity, we selected the C3H/HeOuJ
mouse strain that has been shown to develop fibrosis in other
organs, such as kidney and liver (Campbell et al., 2011; Seki
et al., 2007). Compared to mice fed chow diet, obese mice
fed HFD for 4 weeks showed a higher body weight (27.9 ±
0.4 g versus 35.5 ± 0.5 g, p < 0.001) because of a robust
increase of fat mass (2.6 ± 0.3 g versus 9.1 ± 0.3 g,29, May 22, 2014 ª2014 The Authors 1117
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Figure 2. Time Course Study Shows Development of Fibrosis in Wild-Type, but not in TLR4mut, Mouse Adipose Tissue during High-Fat Diet
(A) mRNA levels of fibrosis genes during high-fat diet (HFD) in wild-type (WT) and TLR4mut epididymal adipose tissue (n = 8 per group).
(B) Representative picrosirius red slides (3100) showing collagen fiber deposition at 12 weeks of HFD.
(C) Quantitation of fibrosis area at different time points (n = 8 per group).
(D) Determination of epididymal fat collagen content by hydroxyproline assay at 12 weeks of HFD (n = 7 per group).
(E) Fibrosis gene expression in progenitors from WT and TLR4mut mice at 6 weeks of HFD (n = 6 per group).
(legend continued on next page)
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p < 0.001). The obese mice also showed an upregulation of
genes involved in fibrosis, notably those encoding ECM pro-
teins (Col1a1, Col6a3, Lum, and Tnc) (Figures 1E and 1F),
which are upregulated in obese humans. This upregulation
was accompanied by an increase of hydroxyproline content,
an indicator of collagen abundance (Figure 1G). In C3H
mice, the fibrotic genes were, as in human AT, preferentially
expressed in SVF progenitor cells (Figures 1H and S1C). In
the commonly used C57BL/6J mouse strain, the upregulation
of fibrosis genes in AT was moderate and observed only after
HFD of extended duration (15 weeks) (Figure S1D,
in comparison to Figure 1F), despite similar gains in weight
(27.7 g ± 1.1 g versus 37.6 ± 1.2 g, p < 0.001) and fat
mass (2.8 ± 0.5 g versus 10.8 ± 0.7 g, p < 0.001) compared
with those observed in C3H/HeOuJ mice fed HFD for
4 weeks. As in C3H/HeOuJ mice, the fibrotic genes were
preferentially expressed in SVF cells compared to mature ad-
ipocytes (Figure S1E). Thus, C3H mice represent a proper
model for studying AT fibrosis during the development of
obesity.
Mutation and Inhibition of TLR4 Protects Mice from
HFD-Induced AT Fibrosis
To determine whether TLR4 was involved in AT fibrosis, we
compared the expression of genes involved in tissue remodeling
in C3H/HeJ mice carrying an inactivating mutation in the Tlr4
gene (TLR4mut mice) with C3H/HeOuJ wild-type (WT) mice dur-
ing a 12 week time course of high-fat feeding. In WT mice,
mRNA levels of Col6a3, Loxl2—which catalyzes the formation
of crosslinks in collagens and elastin—the matrix metallopro-
tease Mmp2, and other fibrotic genes were upregulated after
4 weeks of high-fat feeding (Figures 2A and S2A). In TLR4mut
mice, AT expression of these genes was lower than in WT
mice and showed little progression, if any, during the 12 weeks
of HFD (Figure 2A). Interestingly, fibrosis gene expression was
comparable in AT from WT and TLR4mut mice fed on normal
chow diet for 8 weeks, showing the requirement of, and interac-
tion between, TLR4 and HFD-induced expansion of fat mass to
induce AT fibrosis (Figure S2B). To confirm that an inactive
TLR4 protects from HFD-induced AT fibrosis, the amount of col-
lagens was assessed. Picrosirius staining showed a dramatic in-
crease of collagen deposition and crosslinking in WT epididymal
AT from 6 weeks of HFD, whereas TLR4mut mice were totally
protected (Figures 2B and 2C; Figures S2C and S2D). This result
was confirmed by measurement of hydroxyproline content (Fig-
ure 2D). Gene expression on isolated AT progenitors indicated a
profibrotic profile in WT mice compared to TLR4mut mice (Fig-
ure 2E). We also performed continuous perfusion of a specific
inhibitor of TLR4 signaling (TAK242) in HFD-fed WT mice.
Inhibition of TLR4 signaling with TAK242 limited collagen depo-
sition (Figure 2F). Therefore, genetic, as well as pharmacological,
impairment of TLR4 signaling prevents the development of AT
fibrosis.(F) Representative picrosirius red slides (3100) after treatment with vehicle (DMS
(n = 10 per group).
Values represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
See also Figure S2.
CFibrosis Is Associated with Adipocyte Metabolic
Dysfunction and Death
We also explored the consequences of AT fibrosis on adipocyte
morphology, death, and metabolism in fibrosis-prone WT and
fibrosis-protected TLR4mut mice. Severe fibrosis in epididymal
AT was associated with lower weight of epididymal fat pad in
WT mice (Figures 3A and S2C) and was negatively correlated
with adipocyte size (r = 0.45, p < 0.001) (Figure 3B). AT from
WT mice had numerous perilipin-negative necrotic adipocytes,
whereas those cells were rare in TLR4mut mouse AT (Figure 3C).
The higher rate of adipocyte death was associated with higher
plasma level of FABP4, a cytosolic fatty acid binding protein
released during adipocyte death (Figure 3D).
Fibrosis development was associated with a strong downre-
gulation of genes involved in lipid metabolism in AT from WT
mice, whereas no change was observed in AT from TLR4mut
mice (Figures S3A). This downregulation was confirmed at
the protein level for hormone-sensitive and adipose triglyceride
lipases (Figure S3B). As fibrotic AT was characterized by fat
cell death and numerous nonadipose cells (Figures 3C
and 3E), we pursued metabolic characterization on isolated
intact adipocytes. Perilipin-positive adipocytes were slightly
smaller, and metabolic gene expression was markedly altered
in WT compared to TLR4mut mice (Figures 3F and 3G).
In vitro lipolysis experiments on isolated adipocytes showed
that basal and stimulated glycerol release was lower in WT,
compared to TLR4mut, mice (Figure 3H). Together, these data
suggest a negative association between fibrosis and adipocyte
function.
Mutation of TLR4 Protects Mice from HFD-Induced AT
Macrophage Response
During the development of HFD-induced obesity, expression of
macrophage genes, including Emr1 encoding the specific
marker of macrophages (F4/80), was increased in WT mouse
AT (Figure 4A). The increase was delayed and moderate in
TLR4mut mice. The number of crown-like structures was much
higher in WT, compared with TLR4mut, mouse AT (Figure 4B).
Consistently, flow cytometry analysis performed at 8 weeks of
HFD revealed a higher number of AT macrophages in WT mice
(2.2-fold, p < 0.001) compared to TLR4mut mice (Figure 4C).
These AT macrophages were in majority M2 (CD45+/CD11b+/
F4/80+/CD11c-/CD206+) and M2-like (CD45+/CD11b+/F4/
80+/CD11c-/CD206-) macrophages (Figure 4D) and were ex-
pressed at higher levels in WT mice fed HFD than in those fed
normal chow diet (Figures S4A and S4B). Gene expression per-
formed on isolated macrophages showed higher activation in
WT, compared to TLR4mut, mice (Figure 4E). As mast cells
accumulate in inflamed and fibrotic human fat depots (Divoux
et al., 2012), we investigated the number and location of these
cells in AT from TLR4mut and WT mice. Mast cells were more
numerous in WT, compared to TLR4mut, mice (Figure S4C).
Nevertheless, mast cells were located outside fibrotic areas,O) or TAK242 in WT mice and quantitation of fibrosis area at 8 weeks of HFD
ell Reports 7, 1116–1129, May 22, 2014 ª2014 The Authors 1119
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Figure 3. High-Fat Diet Induces Adipocytes Death and Metabolic Alterations in Adipocytes from Wild-Type, but not TLR4mut, Mice
(A) Epididymal fat-pad weight at 8 and 12 weeks of high-fat diet (HFD) in wild-type (WT) and TLR4mut mice (n = 8 per group).
(B) Correlation between mean area of adipocytes and area of fibrosis determined by picrosirius staining.
(C) Representative immunofluorescence of perilipin 1(PLIN1) staining (3200) and quantitation of PLIN1-negative cells at 12 weeks of HFD (n = 8 per group).
(D) Plasma fatty acid binding protein 4 (FABP4) level after 12 weeks of HFD (n = 8 per group).
(E) Number or nuclei per mm2 at 12 weeks of HFD (n = 8 per group).
(F) Mean area of PLIN1-positive cells at 12 weeks of HFD (n = 8 per group).
(G) Metabolic gene expression in isolated adipocytes at 6 weeks of HFD (n = 6 per group).
(H) Glycerol release during basal and forskolin (FK)-stimulated in vitro lipolysis experiments on isolated adipocytes at 8 weeks of HFD (n = 6 per group).
Values represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S3.
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and their number was very low in comparison to AT macro-
phages (Figure S4D).
The relationship between AT macrophage activation and
fibrosis was shown by the strong positive correlation between
mRNA expression of Emr1 and Col6a3 (r = 0.60, p < 0.001)
(Figure 4F). AT gene expression of the major profibrotic factor
transforming growth factor beta 1 (Tgfb1) was upregulated after
4 weeks of HFD in WT mice (Figure 4G). There were strong cor-
relations between Tgfb1 and Emr1 mRNA expression (r =
0.95 p < 0.001) (Figure 4H) and between Tgfb1 and Col1a1 or
Col6a3 mRNA expression (r = 0.74 p < 0.001; r = 0.43 p < 0.01)
(Figure S4E). Gene expression of the TLR4-downregulated
TGF-b pseudoreceptor, Bambi, was lower in WT, compared
with TLR4mut, mouse AT (Figure S4F).
Macrophage activation and fibrosis were not general features
among tissues from HFD-fed WT mice. In subcutaneous fat,
there was no evidence of fibrosis (Figures S5A and S5B) and
macrophage activation (Figure S5C), unlike in perirenal fat, an in-
traabdominal depot behaving like epididymal fat (Figure S5D). In
liver, fibrosis was not observed after high-fat feeding (Figures
S5E and S5F).
HFD-Induced AT Fibrosis Is Dependent on Immune Cell
Toll-like Receptor 4 and Macrophages
To investigate the involvement of immune cells in the genesis of
AT fibrosis, TLR4mut mice were irradiated. Bone marrow trans-
plantation (BMT) of control or mutated mouse donor cells was
performed into irradiated TLR4mut-recipient mice (BMT-WT
and BMT-TLR4mut mice). The experiment did not alter hemato-
poietic cell lineage distribution in blood. Monocyte, lymphocyte,
and granulocyte counts were similar in the two types of chimeric
mice (Figure S6A). In BMT-WT mice, an intact Tlr4 gene was
detected in blood-hematopoietic-derived cells and in AT
macrophages (Figure S6B). At 8 weeks of HFD, TLR4mut mice
reconstituted with WT bone marrow had higher AT expression
of Tgfb1, Col6a3, and vimentin (Vim) genes compared to BMT-
TLR4mut mice (Figure 5A). Picrosirius staining showed higher
collagen deposition in AT from BMT-WT mice compared to
BMT-TLR4mut mice (Figure 5B). Associated to fibrosis, there
was higher AT expression of Tnf, Ccl2, and Mrc1 macrophage
genes (Figure 5C).
To confirm the involvement of macrophages, we performed
injections of liposomes containing clodronate in WT mice fed
HFD. Clodronate induced a reduction of themacrophagemarker
Emr1 and fibrosis gene mRNA levels, as well as a decrease in
hydroxyproline content (Figures 5D–5F).
Insulin Resistance Is Associated with Immune
TLR4-Mediated AT Fibrosis
The relationship between insulin resistance and AT fibrosis was
investigated in humans and in mice. The quantitative insulin
sensitivity check index (QUICKI) decreased from lean to obese
individuals and reached the lowest levels in obese patients
with metabolic syndrome (Figure 6A). QUICKI values were
negatively correlated with fibrosis gene expression (r = 0.8,
p < 0.001) (Figure 6B).
TLR4mutation prevented the HFD-induced decrease in insulin
tolerance (Figure 6C). This improvement was not related to differ-Cence in weight gain during HFD between WT and TLR4mut mice.
WT mice were more insulin-resistant, i.e., had lower QUICKI
values, than did TLR4mut mice (0.28 ± 0.01 versus 0.42 ± 0.01,
p < 0.001). QUICKI values were negatively correlated to the
extent of AT fibrosis (r = 0.52, p < 0.001) (Figure 6D).
HFD-fed BMT-WT mice were less glucose tolerant than were
BMT-TLR4mut mice (Figure 6E). The insulin 3 glucose product
at 15 min after glucose injection correlated with the extent of
AT fibrosis (r = 0.6, p < 0.01) (Figure 6F).
The TLR4 Ligand LPS Induces AT Fibrosis through
TGFb1
To assess if LPS induces AT fibrosis, we performed continuous
perfusion of LPS for 4 weeks in chow-diet-fed WT mice. This
treatment induced a 2-fold increase in LPS plasma level
(Figure 7A), with no change in body weight (Figure S7A). LPS
perfusion increased expression of several fibrotic genes (Figures
7B and S7B) and surface of fibrotic areas in AT (Figure 7C). AT
macrophage gene expression was also higher (Figure S7C),
together with the number of AT macrophages, chiefly of M2
and M2-like phenotypes, and lymphocytes (Figures 7D and 7E).
To clarify the role of TGFb1 in LPS-induced AT fibrosis, we
performed ex vivo experiments. AT explants treated with LPS
showed an increase of macrophage and fibrosis gene expres-
sion. Addition of a neutralizing antibody against TGFb1 blocked
the effect of LPS on fibrosis gene expression but had only a
limited effect on Tnf gene expression (Figures 7F and 7G).
DISCUSSION
In humans, AT expression of fibrosis-related genes was
increased in obesity and further elevated when obesity and
metabolic syndrome were combined. We identified C3H mice
fed HFD as a suitable model of human obesity-induced AT
fibrosis. In both humans and mice, the extent of AT fibrosis
was linked to the worsening of insulin resistance. Time course
studies in C3H mice revealed that AT expansion was associated
with collagen overproduction, tissue remodeling macrophage
response, and adipocyte metabolic dysfunction and death.
Investigation ofmicewith genetic and pharmacological inhibition
of TLR4 signaling showed that this endotoxin receptor is essen-
tial in mediating the development of AT fibrosis. Bone marrow
transplantation experiments, clodronate-induced depletion of
macrophages, and LPS infusion demonstrated that activation
of macrophage TLR4 is central in AT fibrogenesis and that this
process involves the profibrotic factor TGFb1.
The C57BL/6J strain, traditionally used in obesity research,
appeared, at first glance, as the model of choice to study AT
fibrosis in mice. However, when fed HFD, these mice presented
a late and modest modulation of profibrotic gene expression
(Kwon et al., 2012). This moderate development of AT fibrosis
may be related to lower immune cell infiltration during HFD
compared to C3H mice (Nguyen et al., 2007; Spencer et al.,
2010). The C3H mouse strain represents a more appropriate
model as upon HFD these mice overexpress the same genes
encoding ECM proteins as those upregulated during human
obesity. In both obese individuals and obese C3H mice, genes
related to fibrosis were preferentially expressed in progenitorell Reports 7, 1116–1129, May 22, 2014 ª2014 The Authors 1121
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cells, in line with this cell type being the major matrix producer in
AT (Keophiphath et al., 2009; Lacasa et al., 2007). Time course
studies revealed increased gene expression of two major
collagen species within AT, Col1a1, and Col6a3, resulting in
collagen accumulation and crosslinking. Fibrosis gene expres-
sion was not increased in C3H mice fed chow diet, indicating
that AT expansion and consequent remodeling is a prerequisite
for the development of AT fibrosis. During diet-induced obesity,
there was, however, no evidence of fibrosis in the liver, revealing
that different conditions trigger the appearance fibrosis in the
two organs.
In wound healing, there is an intimate link between fibrosis
and inflammation (Stramer et al., 2007). In AT, flow cytometry
and immunohistochemistry showed a higher amount of immune
cells, notably macrophages, and macrophage marker gene
expression. Macrophages are seen in several organs as master
regulators of fibrosis (Wynn and Barron, 2010). Flow cytometry
analyses showed that alternatively activated M2 was the domi-
nant AT macrophage subset, and M2-like was the most induced
by HFD in our model (Klimcakova et al., 2011a; Morris et al.,
2011; Zeyda et al., 2010). M2 and M2-like macrophages are
involved in tissue repair. Gene expression of macrophage
markers correlated with that of collagens as observed in human
AT (Spencer et al., 2010). Macrophage depletion induced a
reduction of fibrosis-related gene expression and hydroxypro-
line content, indicating a causal link between macrophage acti-
vation during HFD and AT fibrosis. In vitro, human macrophages
impair adipogenesis and promote a profibrotic phenotype in pre-
adipocytes (Keophiphath et al., 2009; Lacasa et al., 2007). Our
data point to macrophages as essential players in the develop-
ment of AT fibrosis by preadipocytes.
There is mounting evidence that AT fibrosis is linked to meta-
bolic dysfunction (Sun et al., 2013). At whole-tissue level, there
was a decrease of epididymal fat-pad weight and fat cell size at
12weeks of HFD inWTmice. Accordingly, we showed a negative
correlation already reported in human AT between the extent of
fibrosis and adipocyte size (Divoux et al., 2010). We also found
a much higher proportion of dead adipocytes in fibrotic AT (Cinti
et al., 2005; Strissel et al., 2007). Patterns of metabolic gene
expression suggested AT metabolic dysfunction in surviving fat
cells. As a representative function, AT from obese WT mice was
characterized by impaired basal and stimulated lipolysis. These
results reveal an intricate combination of AT fibrosis, macro-
phage activation, and adipocyte dysfunction and death that
may contribute to the metabolic complications of obesity. The
strongest signature of genes encoding ECM proteins was found
in obese patients with metabolic syndrome, as also observed inFigure 4. TimeCourse Study ShowsDevelopment ofMacrophage Infiltr
Tissue during High-Fat Diet
(A) mRNA levels of inflammatory genes during high-fat diet (HFD) in wild-type (W
(B) Representative staining (31,000) and quantitation of F4/80-positive crown-lik
(C) Quantitation of stromavascular fraction cell types by flow cytometry at 8 wee
(D) Adipose tissue macrophage phenotyping by flow cytometry at 8 weeks of HF
(E) Gene expression in macrophages of WT and TLR4mut mice at 6 weeks of HF
(F) Correlation between Emr1 and Col6a3 mRNA levels.
(G) mRNA levels of a major profibrotic factor Tgfb1 (n = 8 per group).
(H) Correlation between Emr1 and Tgfb1 mRNA levels.
Values represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figu
Cmorbidly obese patients, indicating a link between AT fibrosis
and worsening of the metabolic status (Henegar et al., 2008).
This was corroborated by the positive association between AT
fibrosis and insulin resistance found both in mice and humans.
TLR4 is a key initiator of macrophage response and a modu-
lator of systemic insulin sensitivity (Saberi et al., 2009; Tsukumo
et al., 2007). Here, we show that obese TLR4mut mice are pro-
tected from AT fibrosis. During HFD, there was no induction of
gene expression and no evidence for deposition of collagens in
AT.Gene expression ofMmp2 andMmp9 encodingmacrophage
matrix metalloproteases and the established profibrotic factor
Tgfb1 were upregulated in WT, but not in TLR4mut, mice. Among
other functions in tissue remodeling, matrix metalloproteases
activate cathepsin-based proteolytic pathways to generate an
active TGFb1. TGFb family members produced bymacrophages
mediate a fibrotic reaction in human AT progenitor cells in vitro
(Bourlier et al., 2012; Keophiphath et al., 2009). Our data support
the role of TGFb1 andmatrix metalloproteases in AT fibrogenesis
in vivo as shown in other tissues (Biernacka et al., 2011; Pardo
and Selman, 2006). BMT revealed that TLR4-competent immune
cells in AT restore the HFD-mediated induction of collagen accu-
mulation and upregulation of macrophage markers, ECM, and
profibrotic genes. Of note, irradiated WT mice transplanted with
bone marrow of TLR4 null mice show markedly reduced mono-
cyte infiltration in AT (Saberi et al., 2009). Furthermore, treatment
with a TLR4 signaling inhibitor protected mice against fibrosis
during HFD. Together, these results show that AT hematopoietic
cell TLR4 is essential for recruitment and activation of macro-
phages, leading to AT fibrosis.
Obesity has been linked to metabolic endotoxemia with an
elevation of circulating LPS levels (Cani et al., 2007). LPS is
considered as the most potent inducer of TLR4. We show that
a moderate increase in LPS plasma levels is sufficient to induce
AT macrophages and fibrosis. Activation of TLR4 by LPS also
induced fibrosis in AT ex vivo. Neutralization of the profibrotic
factor, TGFb1, completely prevented the induction of fibrosis,
suggesting a direct link between the activation of TLR4 by LPS
and AT fibrosis mediated by TGFb1.
Fibrosis, macrophage activation, and adipocyte dysfunction
constitute a detrimental triptych in AT. We found that these intri-
cate processes are dependent on TLR4 expressed in AT macro-
phages. LPS, the main TLR4 ligand, whose plasma levels are
increased during obesity-associated metabolic endotoxemia,
is a likely trigger of AT fibrogenesis. The TLR4-dependent AT re-
modeling leads to limited fat expansion and fibrosis and low
metabolic capacity and necrotic death of fat cells, which concur
to the metabolic complications of obesity.ation and Activation inWild-Type, but not in TLR4mut, Mouse Adipose
T) and TLR4mut adipose tissue (n = 8 per group).
e structures (CLS) (n = 8 per group).
ks of HFD (n = 8 per group).
D (n = 8 per group).
D (n = 6 per group).
res S4 and S5.
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Figure 5. Role of Immune Cell TLR4 and
Macrophages in the Induction of Fibrosis in
Adipose Tissue
Bone marrow transplantation (BMT) of donor cells
from wild-type (WT) or mutated TLR4 (TLR4mut)
mouse was performed into irradiated recipient
TLR4mut mice (BMT-TLR4mut and BMT-WT mice).
Mice were analyzed after 8 weeks of HFD.
(A) mRNA levels of fibrosis genes in BMT experi-
ment (n = 8 per group).
(B) Representative picrosirius red slides (3100)
showing collagen fiber deposition and quantitation
of fibrosis area at 8 weeks of HFD (n = 8 per group).
(C) mRNA levels of macrophage genes (n = 8 per
group).
(D) mRNA levels of the macrophage marker Emr1
(F4/80) in PBS- and clodronate-treated mice (n = 12
per group).
(E) mRNA levels of fibrosis-related genes in PBS-
and clodronate-treated mice (n = 12 per group).
(F) Determination of hydroxyproline content in
adipose tissue at 8 weeks of HFD in PBS- and
clodronate-treated mice (n = 6 per group).
Values represent mean ± SEM. *p < 0.05, **p < 0.01.
See also Figure S6.EXPERIMENTAL PROCEDURES
Expression of Human Fibrosis Genes in Human AT
Clinical studies were approved by the Ethics Committee of the Third Faculty
of Medicine, Charles University, Prague. AT samples were obtained from
carefully phenotyped lean, obese, and obese with metabolic syndrome indi-
viduals (Klimcakova et al., 2011a, 2011b). Adipocytes and SVF were isolated
from subcutaneous AT by collagenase digestion (Klimcakova et al., 2011a).
Progenitor cells from the SVF were differentiated as previously reported
(Rossmeislova´ et al., 2013). Gene expression profiling was performed using
whole-genome 44k oligonucleotide arrays (Agilent Technologies) (Klimca´kova´
et al., 2011b).1124 Cell Reports 7, 1116–1129, May 22, 2014 ª2014 The AuthorsAnimals
Animal protocols were performed in accordance
with French and European Animal Care Facility
guidelines. Five-week-old male C3H/HeJ and
C3H/HeOuJ mice were purchased from the Jack-
son Laboratory. C57BL/6J mice were from Elevage
Janvier.
Diets
After weaning, C3H/HeJ and C3H/HeOuJ mice
were fed with HFD (45% energy as fat, Research
Diets D12451) for 2 to 12 weeks. In some experi-
ments, C3H/HeOuJ mice were fed normal chow
diet (10% energy as fat, Research Diets D12450B)
for 4 weeks. C57BL/6J mice were fed normal
chow and HFD for 15 weeks.
Body Composition
Mouse body composition was evaluated by
quantitative nuclear magnetic resonance imaging
(EchoMRI 3-in-1 system; Echo Medical Systems).
Glucose and Insulin Tolerance Tests
Mice were fasted for 6 hr with free access to
drinking water. Glucose was administered intraper-
itoneally (1 g/kg), and blood glucose levels weremonitored from the tip of the tail with a glucometer (Accucheck, Roche).
At 15 min after glucose injection, blood was collected for insulin quantita-
tion. For insulin tolerance tests, insulin was administered intraperitoneally
(0.6 mU/g), and blood glucose was measured at various times after injection.
Generation of Bone Marrow Chimeras
C3H/HeJ mice at 10 weeks of age received a sublethal dose of whole-body
irradiation (9 Gy). The day after irradiation, donor C3H/HeJ or C3H/HeOuJ
mice were killed, and their femurs and tibias were removed aseptically.
Marrow cavities were flushed, and single-cell suspensions were prepared.
The irradiated recipients received 1 3 107 bone marrow cells in 0.1 ml of
PBS by retro-orbital injection. During 4 weeks after BMT, Bactrim (Roche)
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Figure 6. Insulin Sensitivity Is Associated
with Adipose Tissue Fibrosis in Humans and
Mice
(A) Quantitative insulin sensitivity check index
(QUICKI) values in lean (LE), obese (OB), and obese
with metabolic syndrome (OB/MS) individuals (n = 8
per group).
(B) Correlation between QUICKI and mean centroid
of 18 fibrosis pathway genes in humans.
(C) Insulin tolerance test and weight gain after
8 weeks of high-fat diet in wild-type (WT) or mutated
TLR4 (TLR4mut) mice (n = 8 per group).
(D) Correlation between QUICKI and quantitation of
fibrosis area by picrosirius staining in mice.
(E) Glucose tolerance test and body weight after
8 weeks of high-fat diet in bone-marrow-trans-
planted (BMT) mice (n = 8 per group). See also
Figure 5.
(F) Correlation between insulin 3 glucose levels
determined at 15 min after glucose injection and
quantitation of fibrosis area by picrosirius staining
in BMT mice.
Values represent mean ± SEM. *p < 0.05, ***p <
0.001was added to drinking water. After 2 additional weeks, mice were switched to
HFD. Mice were killed 8 weeks later to collect blood and tissues.
LPS and TAK242 Continuous Infusions
For LPS infusion, 5-week-old mice fed normal chow diet were implanted intra-
peritoneally with an osmotic minipump (Alzet Model 1004). Pumps were filled
either with NaCl (0.9%) or LPS (from Escherichia coli 055:B5; Sigma) to infuse
300 mg kg1$day1 for 4 weeks.
ForTAK242 infusion,micewere fedHFD for4weeksand then implanted intra-
peritoneally with osmotic minipumps filled either with a solution of DMSO/
ethanol/H2O (5/1.5/3.5) or TAK242 (Invivogen) to infuse 350 mg kg
1$day1 for
4 weeks during HFD feeding.
Macrophage Depletion by Liposome-Encapsulated Clodronate
C3H/HeOuJ mice were fed HFD and concomitantly received intraperitoneally
250 ml liposomes containing clodronate (5 mg/ml) or an equivalent volume of
liposomes containing PBS once per week for 8 weeks (Dr van Rooijen, Vrije
Universiteit).
Analysis of Blood Parameters
Plasma glucose levels were measured by an enzymatic assay kit (Glucose
RTU, Biomerieux). Serum insulin concentration was determined by an
enzyme-linked immunosorbent assay (Mouse Ultrasensitive Insulin ELISA,
ALPCO Diagnostics). Plasma LPS levels were measured through the quantita-
tion of 3-b-hydroxymyristate (Nguyen et al., 2013). Plasma FABP4 concentra-
tion was determined by enzyme immunoassay (BioVendor, R&D).Cell Reports 7, 1116–11In Vitro Lipolysis Experiments
Isolated packed adipocytes were diluted and incu-
bated in Krebs-Ringer bicarbonate buffer with 2%
fatty acid-free BSA and 1 g/l glucose containing for-
skolin (105 M) for maximal lipolysis determination.
Glycerol was measured by free glycerol reagent
(Sigma). Total lipid content was determined gravi-
metrically after organic extraction.
Explant Protocol
Epididymal fat pad of C3H/HeOuJ mice at
6 weeks of HFD was dissected, cut into small
pieces, distributed in well plates containingECBM (PromoCell) supplemented with 0.1% fatty acid-BSA, and incubated
at 37C with 5% CO2 for 1 hr. AT was then treated with 100 ng/ml LPS
(Invivogen) or NaCl in the presence of a neutralizing antibody against
TGFb1 (1 mg/ml) for 24 hr or a immunoglobulin G (IgG) isotype control
(R&D Systems). At the end of the incubation period, AT was frozen in liquid
nitrogen and stored at 80C.
Flow Cytometry Analysis, Immunophenotyping, and Cell Sorting
Fat pads were digested by a cocktail of collagenases. Digested tissues were
filtered through a 225 mmpore filter. SVFwas separated from remaining fibrous
material and floating adipocytes by centrifugation at 300 3 g. SVF cells were
then filtered through a 70 mm pore filter and incubated in an erythrocyte lysing
buffer. Cells (106) were incubated 10 min at room temperature with Fcblock
(BD Biosciences) in flow cytometry buffer (PBS, 0.2% BSA, 2 mM EDTA).
For flow cytometry analysis, pools of specific fluorescent-labeled antibodies
(PerCP-CD45, FITC-F4/80, APC-Cy7-CD11b, PE-Cy7-CD11c, PE-CD206,
APC-CD31, PE-CD34, FITC-Sca1, PE-CD3, FITC-CD4, and APC-CD8 from
BD Biosciences) were prepared and added to the SVF solution. After an incu-
bation of 30 min on ice in the dark, cells were washed with 2 ml of PBS and
centrifuged at 300 3 g, 10 min at 4C. Supernatant was discarded, and the
cell pellet was resuspended in 0.5 ml of PBS.
For cell sorting, pools of specific fluorescent-labeled antibodies (PerCP-
CD45, PE-F4/80, APC-CD31, and Brilliant Violet-Sca1 from BD Biosciences)
were prepared and added to the SVF solution. After 30 min incubation on
ice, cells were washed with 2 ml of cold PBS and centrifuged at 300 3 g,
10 min at 4C. Supernatant was discarded, and the cell pellet was29, May 22, 2014 ª2014 The Authors 1125
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Figure 7. Lipopolysaccharide Treatment Promotes Adipose Tissue Fibrosis via the TGFb1 Pathway
(A) Fasting plasma lipopolysaccharide (LPS) levels after 4 weeks of NaCl or LPS infusion (n = 9 per group).
(B) mRNA levels of fibrosis genes after 4 weeks of NaCl or LPS infusion (n = 9 per group).
(C) Representative picrosirius red slides (3100) showing collagen fiber deposition and quantitation of fibrosis area.
(legend continued on next page)
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resuspended in 1 ml of PBS. Macrophages stained with PerCP-C45 and PE-
F4/80 were separated from progenitors stained with Brilliant Violet-Sca1 using
a fluorescence-activated cell sorter. Macrophages and progenitor cells were
collected and immediately frozen for gene expression analysis.
RNA Extraction and Real-Time PCR
Total RNA was extracted using RNeasy or RNeasy Micro Kits (QIAGEN).
RNA was quantified by Nanodrop spectrophotometer (ND-1000, Nanodrop
Technologies). RNA (200 ng to 1 mg) was reverse transcribed using the
Multi-Reverse Transcriptase Kit (Invitrogen). mRNA levels were measured by
quantitative RT-PCR using Applied Biosystems StepOne or the Fluidigm Bio-
mark system (Viguerie et al., 2012). Taqman probes were provided by Applied
Biosystems. SYBR Green primers are listed in Table S2.
Western Blot Analysis
AT were homogenized using the Precellys 24 apparatus (Bertin) in a buffer
containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% NP40, 0.5% Sodium
deoxycholate, 0.1% SDS, 10 ml/ml protease inhibitor, 10 ml/ml phosphatase I
inhibitor, and 10 ml/ml phosphatase II inhibitor. Tissue lysates were centrifuged
at 14,000 g for 30 min at 4C, and supernatants were stored at 80C. Solu-
bilized proteins (30 mg) from AT were run on 4%–12% gradient SDS-PAGE
(Biorad) transferred onto nitrocellulose membrane (Hybond ECL, Amersham
Biosciences) and incubated with primary antibodies against ATGL and HSL
(Cell Signaling Technology). Subsequently, immunoreactive proteins were
determined by chemiluminescence (SuperSignal West Dura Thermo Scienti-
fic). For loading controls, proteins were detected directly with the Criterion
Stain Free Gel Imaging System (BioRad).
Histological Analysis
AT was fixed with neutral-buffered formalin 10% for 24 hr, embedded in
paraffin, sectioned, and stained with picrosirius dye. Fibrosis quantification
was performed after picrosirius staining using ImageJ.
For mast cells staining, slides were stained in toluidine blue solution (Sigma).
Mast cells were counted on the basis of metachromatic staining of their cyto-
plasmic granules by toluidine blue.
Immunohistochemistry and Immunofluorescence
For immunofluorescence, AT serial sections were incubated overnight at room
temperature in a humid chamber with anti-perilipin antibody (GP 29 Progen)
diluted at 1:200 in a solution containing 0.1% of BSA and 0.05% of Tween
20. After three washes in PBS, immunofluorescence was detected following
incubation with Alexa Fluor 568 anti-guinea pig diluted at 1:200. For nucleus
staining, Hoechst 33342 (5 mg/ml) was added to section and stained for
5 min at room temperature. Slides were mounted and processed for micro-
scope observation.
For immunohistochemistry, adipose fat serial sections were incubated
overnight at room temperature in a humid chamber with anti-F4/80 antibody
(AbD serotec) diluted at 10 ng/ml. After three washes in TBS buffer, incubation
for 1 hr in the appropriate secondary biotinylated antibody was performed.
Staining was revealed with diaminobenzidine (DAB 1%).
Hydroxyproline Assay
Frozen AT (100mg) was heated in 6 NHCl at 120C for 4 hr in sealed tubes. The
samples were centrifuged, and 10 ml of supernatant was mixed with 100 ml of
chloramine-T solution (1.4% chloramine-T, 10%N-propanol, and 80%citrate-
acetate buffer). This mixture was incubated for 20 min at room temperature.
Ehrlich’s solution was added, and the samples were incubated at 65C for
20 min. The absorbance was read at 540 nm, and the concentration was
determined by the standard curve created by cis-4-hydroxy-L-proline
(Sigma-Aldrich).(D) Quantitation of stromavascular fraction cell types in adipose tissue by flow c
(E) Adipose tissue macrophage phenotyping by flow cytometry after 4 weeks of
(F) mRNA levels of Tnf and fibrosis genes in mouse adipose explants treated wit
(G) Centroid analysis of five fibrosis pathway genes in mouse adipose explants t
Values represent mean ± SEM (n = 8 per group). *p < 0.05, **p < 0.01, ***p < 0.0
CStatistical Analysis
All statistical analyses were performed using GraphPad Prism (v. 5.0) for Win-
dows (GraphPad Software). Normal distribution of the data was tested with
Kolmogorov-Smirnov tests. Paired or unpaired Student’s t tests were per-
formed to determine differences between groups. Two-way ANOVA, followed
by Bonferroni’s post hoc tests, was applied when appropriate. Pearson cor-
relations were applied when data were normally distributed, and Spearman
correlations were applied for nonparametric data. All values in figures and
tables are presented as mean ± SEM. Statistical significance was set at
p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
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